Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2015 13:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Date Change for Second Quarter 2015 Financial Results

BUFFALO, NY--(Marketwired - Jul 31, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on August 12, 2015, it will report its financial results for the second quarter and...
July 21, 2015 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Report Second Quarter 2015 Financial Results on August 3

BUFFALO, NY--(Marketwired - Jul 21, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on August 3, 2015, it will report its financial results for the second quarter and...
July 16, 2015 08:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Stockholders' Equity Requirement

BUFFALO, NY--(Marketwired - Jul 16, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on July 15, 2015, the Company received a letter from The Nasdaq Stock Market LLC stating that...
July 13, 2015 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Results of Phase 1 Study of CBLB612 in Russian Federation

BUFFALO, NY--(Marketwired - Jul 13, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the results of a Phase 1 single-blinded, randomized, placebo-controlled, healthy-subject...
July 10, 2015 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Board Appointments

BUFFALO, NY--(Marketwired - Jul 10, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the appointment of Mses. Anna Evdokimova, Natalia Khudyk, Yulia Lebedina, Tatiana Levina,...
July 09, 2015 09:15 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Closes Private Placement With Strategic Investor for $25 Million Equity Financing

BUFFALO, NY--(Marketwired - Jul 9, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has successfully closed a private placement with David Davidovich, a venture capital...
June 25, 2015 07:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Enters Into Private Placement Agreement With Strategic Investor for $25 Million Equity Financing

BUFFALO, NY--(Marketwired - Jun 25, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has entered into a securities purchase agreement with David Davidovich, a venture...
June 15, 2015 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Submits Pre-EUA Dossier for Entolimod to FDA

BUFFALO, NY--(Marketwired - Jun 15, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the company has submitted an application for pre-Emergency Use Authorization (pre-EUA) to the...
June 01, 2015 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Releases Entolimod Phase 1 Study Findings at ASCO

BUFFALO, NY--(Marketwired - Jun 1, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the release of results from a Phase 1 open-label, dose-escalation trial of entolimod in patients...
May 06, 2015 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Reports First Quarter 2015 Financial Results and Development Progress

BUFFALO, NY--(Marketwired - May 6, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the first quarter ended March 31, 2015. ...